From: The prognostic value of the nodal ratio in N1 breast cancer
 | No. of patients (%) |  |  |  |
---|---|---|---|---|
 | NR < 0.15 (n = 100) | NR > 0.15 (n = 30) | p value | Total (n = 130) |
Age (years) | Â | Â | 0.225 | Â |
   median (range) | 46 (25-79) | 50 (32-82) |  | 47 (25-82) |
Excised LN (No.) | Â | Â | < 0.001 | Â |
   median (range) | 20 (7-59) | 7 (1-18) |  | 18 (1-59) |
Breast resection | Â | Â | 0.290 | Â |
   BCS | 49 (49.0) | 18 (60.0) |  | 67 (51.5) |
   MRM | 51 (51.0) | 12 (40.0) |  | 63 (48.5) |
LN resection | Â | Â | 0.071 | Â |
   SLNB only | 3 (3.0) | 4 (13.3) |  | 7 (5.4) |
   SLNB + ALND | 68 (68.0) | 20 (66.7) |  | 88 (67.7) |
   ALND | 29 (29.0) | 6 (20.0) |  | 35 (26.9) |
Radiotherapy | Â | Â | 0.047 | Â |
   no | 54 (54.0) | 10 (33.3) |  | 64 (49.2) |
   yes | 46 (46.0) | 20 (66.7) |  | 66 (50.8) |
Extent of radiotherapy | Â | Â | 0.001 | Â |
   local | 41 (89.1) | 10 (50.0) |  | 51 (77.2) |
   locoregional | 5 (10.9) | 10 (50.0) |  | 15 (22.8) |
Chemotherapy | Â | Â | 0.176 | Â |
   no | 8 (8.0) | 5 (16.7) |  | 13 (10.0) |
   yes | 92 (92.0) | 25 (83.3) |  | 117 (90.0) |
Regimen | Â | Â | 0.141 | Â |
   CMF | 12 (13.0) | 7 (28.0) |  | 19 (16.2) |
   FEC/FAC | 31 (33.7) | 9 (36.0) |  | 40 (34.2) |
   ACT | 49 (53.3) | 9 (36.0) |  | 58 (49.6) |